13 April 2021 To ensure the latest information is available, the landscape will be updated twice a week These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all) representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss, damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of these landscape documents

Der Aufklärungsbogen in einfacher Sprache kann in zahlreichen weiteren Sprachen heruntergeladen werden kann: Albanisch, Arabisch,Bulgarisch, Dari, Englisch, Französisch, Kroatisch, Pashtu, Persisch, Polnisch, Rumänisch, Russisch, Serbisch, Spanisch, Tigrinisch, Türkisch, Urdu, Vietnamesisch https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/COVID-19-Aufklaerungsbogen-Tab.htm

1 April 2021

INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit mRNA-Impfstoffen – Erklärung für die Formulare

Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen

INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit mRNA-Impfstoffen – Erklärung für die Formulare

Issue Brief no.8. January 18,2021 Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies, implementation of the vaccination, ethical considerations, as well as educational materials in English and other languages

A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.

COVID Reference 13 Janaury 2020 As of 8 January, three vaccines had been approved in Europe and in the US: tozinameran (Comirnaty™) by BioNTech/Pfizer (formerly known as BNT162b2), mRNA-1273 by Moderna and ChAdOx1 nCoV-19 by University of Oxford/AstraZeneca. Adverse events such as pain at injection site, fatigue, headache, myalgia and fever were common, but serious adverse events were rare. All three vaccines seem to have a favorable safety profile. Three other vaccine candidates have been approved (not by FDA or EMA) although data are incomplete or have not yet been published: China: BBIBP-CorV (30 December), Sinopharm and the Beijing Institute of Biological Products India: Covaxin (3 January), Bharat Biotech Russia: Sputnik-V (28 December), Gamaleya Research Institute In early January 2021, 63 vaccine candidates were in clinical development against SARS-CoV-2 and 172 in pre-clinical development

1 April 2021 Neben der Terminbestätigung sollte der Impfausweis, falls vorhanden, zu der Impfung mitgebracht werden. Falls vorhanden, sollten auch wichtige Unterlagen wie ein Herzpass, ein Diabetikerausweis oder eine Medikamentenliste mitgebracht werden. Zur Vorbereitung können Sie sich bereits die Aufklärungsbögen des RKI herunterladen: Einwilligungserklärung in die Schutzimpfung gegen COVID-19 Aufklärungsmerkblatt zur Schutzimpfung gegen COVID-19 Hinweise zur Impfaufklärung. Diese finden Sie alle hier in der MEDBOX und COVID-19 Toolbox. Es wurde ebenfalls ein Aufklärungsbogen in einfacher Sprache erstellt, der in zahlreichen Sprachen heruntergeladen werden kann: https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/COVID-19-Aufklaerungsbogen-Tab.htm